https://www.selleckchem.com/products/h2dcfda.html
Retrospective cohort study. To assess long-term clinical outcomes of adjacent segment disease (ASD) in patients who underwent lumbar interbody fusion with percutaneous pedicle screw (PS) instrumentation. ASD is a well-known sequela of spinal fusion, and is reported to occur at a rate of 2%-3% per year. There is debate as to whether ASD is a result of the instrumentation and fusion method or is the natural history of the patient's disease. Minimally invasive percutaneous PS augmentation of lumbar interbody fusion aims to prevent the disr
Like
Comment
Share
